CVS’s stock impacted as Medicare Advantage issues weigh on results

May 2, 2024- Shares of CVS Health Corp suffered the biggest drop in 15 years, according to MarketWatch, after the pharmacy/healthcare-services company missed first quarter earnings expectations. The Medicare Advantage business weighed heavily on the business results.

CVS said it now expects 2024 adjusted earnings of at least $7.00 per share, down from its prior view of at least $8.30. CVS said it anticipates the surge in medical procedures that fueled higher costs for its Aetna health insurance unit to persist through the year, according to Reuters.

Learn More

Learn More from MarketWatch

safe online pharmacy for viagra cheap kamagra oral jelly online